149 related articles for article (PubMed ID: 35662347)
1. Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study.
Wada K; Nakashima Y; Yamakawa M; Hori A; Seishima M; Tanabashi S; Matsushita S; Tokimitsu N; Nagata C
Cancer Sci; 2022 Aug; 113(8):2839-2848. PubMed ID: 35662347
[TBL] [Abstract][Full Text] [Related]
2. Dietary Intake of Nε-carboxymethyl-lysine, a Major Advanced Glycation End Product, is Not Associated with Increased Risk of Mortality in Japanese Adults in the Takayama Study.
Nagata C; Wada K; Yamakawa M; Nakashima Y; Koda S; Uji T; Oba S
J Nutr; 2020 Oct; 150(10):2799-2805. PubMed ID: 32840609
[TBL] [Abstract][Full Text] [Related]
3. Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.
Jiao L; Stolzenberg-Solomon R; Zimmerman TP; Duan Z; Chen L; Kahle L; Risch A; Subar AF; Cross AJ; Hollenbeck A; Vlassara H; Striker G; Sinha R
Am J Clin Nutr; 2015 Jan; 101(1):126-34. PubMed ID: 25527756
[TBL] [Abstract][Full Text] [Related]
4. Dietary melatonin and liver cancer incidence in Japan: From the Takayama study.
Wada K; Hattori A; Maruyama Y; Mori T; Sugino M; Nakashima Y; Yamakawa M; Yamamoto M; Hori A; Seishima M; Tanabashi S; Matsushita S; Nagata C
Cancer Sci; 2024 May; 115(5):1688-1694. PubMed ID: 38356184
[TBL] [Abstract][Full Text] [Related]
5. Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).
Omofuma OO; Turner DP; Peterson LL; Merchant AT; Zhang J; Steck SE
Cancer Prev Res (Phila); 2020 Jul; 13(7):601-610. PubMed ID: 32169887
[TBL] [Abstract][Full Text] [Related]
6. Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults.
Cordova R; Knaze V; Viallon V; Rust P; Schalkwijk CG; Weiderpass E; Wagner KH; Mayen-Chacon AL; Aglago EK; Dahm CC; Overvad K; Tjønneland A; Halkjær J; Mancini FR; Boutron-Ruault MC; Fagherazzi G; Katzke V; Kühn T; Schulze MB; Boeing H; Trichopoulou A; Karakatsani A; Thriskos P; Masala G; Krogh V; Panico S; Tumino R; Ricceri F; Spijkerman A; Boer J; Skeie G; Rylander C; Borch KB; Quirós JR; Agudo A; Redondo-Sánchez D; Amiano P; Gómez-Gómez JH; Barricarte A; Ramne S; Sonestedt E; Johansson I; Esberg A; Tong T; Aune D; Tsilidis KK; Gunter MJ; Jenab M; Freisling H
Eur J Nutr; 2020 Oct; 59(7):2893-2904. PubMed ID: 31701336
[TBL] [Abstract][Full Text] [Related]
7. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
8. Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition.
Zhang Y; Jiang F; Liu D; Li X; Ma Z; Zhang Y; Ma A; Qin LQ; Chen GC; Wan Z
Clin Nutr; 2023 Sep; 42(9):1788-1797. PubMed ID: 37586315
[TBL] [Abstract][Full Text] [Related]
9. Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative.
Omofuma OO; Peterson LL; Turner DP; Merchant AT; Zhang J; Thomson CA; Neuhouser ML; Snetselaar LG; Caan BJ; Shadyab AH; Saquib N; Banack HR; Uribarri J; Steck SE
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2217-2226. PubMed ID: 34583965
[TBL] [Abstract][Full Text] [Related]
10. Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults.
Jahromi MK; Tehrani AN; Farhadnejad H; Emamat H; Ahmadirad H; Teymoori F; Heidari Z; Saber N; Rashidkhani B; Mirmiran P
BMC Cancer; 2023 Oct; 23(1):932. PubMed ID: 37789296
[TBL] [Abstract][Full Text] [Related]
11. Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.
Linkens AMA; Houben AJHM; Kroon AA; Schram MT; Berendschot TTJM; Webers CAB; van Greevenbroek M; Henry RMA; de Galan B; Stehouwer CDA; Eussen SJMP; Schalkwijk CG
Am J Clin Nutr; 2022 Feb; 115(2):444-455. PubMed ID: 34581759
[TBL] [Abstract][Full Text] [Related]
12. Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
Aglago EK; Mayén AL; Knaze V; Freisling H; Fedirko V; Hughes DJ; Jiao L; Eriksen AK; Tjønneland A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Katzke V; Schulze MB; Birukov A; Palli D; Sieri S; Santucci de Magistris M; Tumino R; Ricceri F; Bueno-de-Mesquita B; Derksen JWG; Skeie G; Gram IT; Sandanger T; Quirós JR; Luján-Barroso L; Sánchez MJ; Amiano P; Chirlaque MD; Gurrea AB; Johansson I; Manjer J; Perez-Cornago A; Weiderpass E; Gunter MJ; Heath AK; Schalkwijk CG; Jenab M
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579010
[TBL] [Abstract][Full Text] [Related]
13. Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.
Peterson LL; Park S; Park Y; Colditz GA; Anbardar N; Turner DP
Cancer; 2020 Jun; 126(11):2648-2657. PubMed ID: 32097496
[TBL] [Abstract][Full Text] [Related]
14. Soy Isoflavone Intake and Bladder Cancer Risk in Japan: From the Takayama Study.
Wada K; Tsuji M; Tamura T; Konishi K; Goto Y; Mizuta F; Koda S; Uji T; Hori A; Tanabashi S; Matsushita S; Tokimitsu N; Nagata C
Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1371-1375. PubMed ID: 30131436
[No Abstract] [Full Text] [Related]
15. Correlation between serum advanced glycation end products and dietary intake of advanced glycation end products estimated from home cooking and food frequency questionnaires.
Vasilj M; Goni L; Gayoso L; Razquin C; Sesma MT; Etxeberria U; Ruiz-Canela M
Nutr Metab Cardiovasc Dis; 2023 Sep; 33(9):1768-1777. PubMed ID: 37414659
[TBL] [Abstract][Full Text] [Related]
16. Is dietary intake of advanced glycation end products associated with mortality among adults with diabetes?
Koyama AK; Pavkov ME; Wu Y; Siegel KR
Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1402-1409. PubMed ID: 35282981
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Dietary Advanced Glycation End-Product (dAGE) Exposure and the Relationship to Colorectal Adenoma Recurrence: A Secondary Analysis.
Sfeir M; Jacobs ET; Kohler LN; Steck SE; Yung AK; Thomson CA
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904125
[TBL] [Abstract][Full Text] [Related]
18. Soy isoflavone intake and stomach cancer risk in Japan: From the Takayama study.
Wada K; Tsuji M; Tamura T; Konishi K; Kawachi T; Hori A; Tanabashi S; Matsushita S; Tokimitsu N; Nagata C
Int J Cancer; 2015 Aug; 137(4):885-92. PubMed ID: 25639758
[TBL] [Abstract][Full Text] [Related]
19. Perspective: The Paradox in Dietary Advanced Glycation End Products Research-The Source of the Serum and Urinary Advanced Glycation End Products Is the Intestines, Not the Food.
DeChristopher LR
Adv Nutr; 2017 Sep; 8(5):679-683. PubMed ID: 28916568
[TBL] [Abstract][Full Text] [Related]
20. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.
Jiao L; Kramer JR; Chen L; Rugge M; Parente P; Verstovsek G; Alsarraj A; El-Serag HB
Aliment Pharmacol Ther; 2013 Oct; 38(7):817-24. PubMed ID: 23957669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
